Naoki Washida

1.2k total citations
50 papers, 883 citations indexed

About

Naoki Washida is a scholar working on Nephrology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Naoki Washida has authored 50 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Nephrology, 11 papers in Surgery and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Naoki Washida's work include Dialysis and Renal Disease Management (28 papers), Blood Pressure and Hypertension Studies (6 papers) and Central Venous Catheters and Hemodialysis (6 papers). Naoki Washida is often cited by papers focused on Dialysis and Renal Disease Management (28 papers), Blood Pressure and Hypertension Studies (6 papers) and Central Venous Catheters and Hemodialysis (6 papers). Naoki Washida collaborates with scholars based in Japan, Israel and Portugal. Naoki Washida's co-authors include Shu Wakino, Hiroshi Itoh, Kôichi Hayashi, Hirobumi Tokuyama, Kazuhiro Hasegawa, Hitoshi Minakuchi, Yoshikazu Hara, Kyoko Yoshioka, Satoru Tatematsu and Hiroshi Itoh and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Naoki Washida

45 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naoki Washida Japan 13 249 246 214 185 174 50 883
David Legouis Switzerland 16 266 1.1× 307 1.2× 113 0.5× 125 0.7× 155 0.9× 34 963
Zengchun Ye China 21 325 1.3× 437 1.8× 100 0.5× 50 0.3× 153 0.9× 47 1.2k
Sheng An China 12 106 0.4× 340 1.4× 88 0.4× 124 0.7× 223 1.3× 16 862
Yibing Lu China 16 70 0.3× 306 1.2× 119 0.6× 67 0.4× 175 1.0× 34 756
Satoshi Iimuro Japan 21 207 0.8× 370 1.5× 248 1.2× 34 0.2× 153 0.9× 34 1.4k
Masahito Imanishi Japan 24 328 1.3× 258 1.0× 212 1.0× 51 0.3× 122 0.7× 73 1.4k
Ajay Kher United States 12 296 1.2× 287 1.2× 111 0.5× 17 0.1× 182 1.0× 26 994
Núria Alonso Spain 22 68 0.3× 255 1.0× 235 1.1× 67 0.4× 253 1.5× 92 1.4k
Keven Ang Singapore 18 168 0.7× 175 0.7× 235 1.1× 27 0.1× 120 0.7× 77 853
Elettra Mancuso Italy 11 122 0.5× 213 0.9× 154 0.7× 15 0.1× 120 0.7× 25 678

Countries citing papers authored by Naoki Washida

Since Specialization
Citations

This map shows the geographic impact of Naoki Washida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Washida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Washida more than expected).

Fields of papers citing papers by Naoki Washida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Washida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Washida. The network helps show where Naoki Washida may publish in the future.

Co-authorship network of co-authors of Naoki Washida

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Washida. A scholar is included among the top collaborators of Naoki Washida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Washida. Naoki Washida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Morimoto, Kohkichi, Kiyotaka Uchiyama, Naoki Washida, et al.. (2024). Efficacy of sucrose and povidone–iodine mixtures in peritoneal dialysis catheter exit-site care. BMC Nephrology. 25(1). 151–151.
3.
Uchiyama, Kiyotaka, et al.. (2024). Acute Kidney Injury Associated With Red Yeast Rice (Beni-kōji) Supplement: A Report of Two Cases. Kidney Medicine. 6(11). 100908–100908. 4 indexed citations
4.
Ito, Wataru, Kiyotaka Uchiyama, Takashin Nakayama, et al.. (2023). Correlation between acylcarnitine/free carnitine ratio and cardiopulmonary exercise test parameters in patients with incident dialysis. Frontiers in Physiology. 14. 1155281–1155281.
5.
Uchiyama, Kiyotaka, Takashin Nakayama, Rina Takahashi, et al.. (2023). Clinical significance of serum urea‐to‐creatinine ratio in patients undergoing peritoneal dialysis. Therapeutic Apheresis and Dialysis. 27(6). 1103–1112. 1 indexed citations
6.
Uchiyama, Kiyotaka, Takashin Nakayama, Rina Takahashi, et al.. (2023). Comparison of the effects of angiotensin receptor–neprilysin inhibitors and thiazide diuretic/renin–angiotensin system inhibitor combination therapy in hypertensive patients: a retrospective cohort study. Journal of Human Hypertension. 37(12). 1049–1055. 7 indexed citations
7.
Uchiyama, Kiyotaka, Takashin Nakayama, Satoshi Kinugasa, et al.. (2023). Peritoneal dialysis-related peritonitis with encapsulated ascites due to Mycobacterium abscessus subsp. massilience and subsp. bolletii: a case series and literature review. Renal Replacement Therapy. 9(1). 1 indexed citations
8.
Takahashi, Rina, Kiyotaka Uchiyama, Naoki Washida, et al.. (2023). Mean annual intradialytic blood pressure decline and cardiovascular events in Japanese patients on maintenance hemodialysis. Hypertension Research. 46(6). 1536–1546. 2 indexed citations
9.
Nakayama, Takashin, Kiyotaka Uchiyama, Kohkichi Morimoto, et al.. (2022). Late Dialysis Modality Education Could Negatively Predict Peritoneal Dialysis Selection. Journal of Clinical Medicine. 11(14). 4042–4042. 1 indexed citations
10.
Uchiyama, Kiyotaka, Takashin Nakayama, Rina Takahashi, et al.. (2022). Effect of Tolvaptan in Patients with Chronic Kidney Disease Stage G5, and Impact of Concomitant Use of Thiazide Diuretics: A Retrospective Cohort Study. Drugs - Real World Outcomes. 9(4). 649–657. 1 indexed citations
11.
12.
Uchiyama, Kiyotaka, et al.. (2021). Seasonal variation and predictors of intradialytic blood pressure decline: a retrospective cohort study. Hypertension Research. 44(11). 1417–1427. 4 indexed citations
13.
Nakayama, Takashin, Kiyotaka Uchiyama, Kohkichi Morimoto, et al.. (2021). Efficacy of dexmedetomidine on peritoneal dialysis catheter insertion. International Urology and Nephrology. 54(1). 209–215. 2 indexed citations
14.
Uchiyama, Kiyotaka, Naoki Washida, Kohkichi Morimoto, et al.. (2019). Home-based Aerobic Exercise and Resistance Training in Peritoneal Dialysis Patients: A Randomized Controlled Trial. Scientific Reports. 9(1). 2632–2632. 43 indexed citations
15.
Fujii, Kentaro, Naoki Washida, Eri Arai, et al.. (2018). Adhesive intestinal obstruction increases the risk of intestinal perforation in peritoneal dialysis patients: a case report. BMC Nephrology. 19(1). 153–153. 2 indexed citations
16.
Washida, Naoki & Hiroshi Itoh. (2018). The Role of Non-Tuberculous Mycobacteria in Peritoneal Dialysis-Related Infections: A Literature Review. Contributions to nephrology. 196. 155–161. 15 indexed citations
17.
Washida, Naoki, Kentaro Fujii, Kiyotaka Uchiyama, et al.. (2018). Penile calciphylaxis in a patient on combined peritoneal dialysis and hemodialysis. CEN Case Reports. 7(2). 204–207. 3 indexed citations
18.
Nitta, Kosaku, Ikuto Masakane, Tadashi Tomo, et al.. (2017). Policy for developing clinical practice guidelines of Japanese Society for Dialysis Therapy. Renal Replacement Therapy. 3(1). 5 indexed citations
19.
Washida, Naoki, Shuji Inoue, Kohkichi Morimoto, et al.. (2015). Impact of Peritoneal Dialysis Catheter Insertion by a Nephrologist: Results of a Questionnaire Survey of Patients and Nurses.. PubMed. 31. 59–68. 4 indexed citations
20.
Hosoya, Kozi, Hitoshi Minakuchi, Shu Wakino, et al.. (2014). Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans. Kidney International. 87(4). 749–760. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026